Cargando…
Medication Adherence in Indian Epilepsy Patients
PURPOSE: While two-thirds of epilepsy patients can become seizure free on medical treatment, poor adherence to medication is a major problem to sustained remission and functional restoration. The aim of this study was to assess the prevalence and associated factors of antiepileptic drug (AED) non-ad...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513971/ https://www.ncbi.nlm.nih.gov/pubmed/34728941 http://dx.doi.org/10.4103/aian.AIAN_925_20 |
_version_ | 1784583305145876480 |
---|---|
author | Kumar, Shrawan Singh, Mamta Bhushan Kumar, Amit Padma Srivastava, M V Goyal, Vinay |
author_facet | Kumar, Shrawan Singh, Mamta Bhushan Kumar, Amit Padma Srivastava, M V Goyal, Vinay |
author_sort | Kumar, Shrawan |
collection | PubMed |
description | PURPOSE: While two-thirds of epilepsy patients can become seizure free on medical treatment, poor adherence to medication is a major problem to sustained remission and functional restoration. The aim of this study was to assess the prevalence and associated factors of antiepileptic drug (AED) non-adherence. METHODS: We conducted a subgroup analysis based on results that emerged from a single center, cross-sectional study. Patients who were 18 years or older were included. The 4-item Morisky Medication Adherence Scale was used to measure adherence to AED (s). Multivariable logistic regression analysis was used to predict factors associated with AED non-adherence. RESULTS: A total of 268 patients fulfilled inclusion criteria and were included in this subgroup analysis. Among the participants, 81 (30%) were non-adherent to medication. Three factors associated with non-adherence were AED polytherapy [OR: 4.5 (2.1-9.5) P = 0.001], drug related adverse events [OR: 3.9 (2.1-7.3) P = 0.001], and treatment duration exceeding 3 years [OR: 2.6 (1.3-5.0) P = 0.003]. CONCLUSION: About one-third patients were not compliant with their medication. If the treatment of patients is restricted to monotherapy as far as possible and patients are educated about duration of treatment and possible adverse effects of AEDs, non-adherence may be reduced. |
format | Online Article Text |
id | pubmed-8513971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-85139712021-11-01 Medication Adherence in Indian Epilepsy Patients Kumar, Shrawan Singh, Mamta Bhushan Kumar, Amit Padma Srivastava, M V Goyal, Vinay Ann Indian Acad Neurol Original Article PURPOSE: While two-thirds of epilepsy patients can become seizure free on medical treatment, poor adherence to medication is a major problem to sustained remission and functional restoration. The aim of this study was to assess the prevalence and associated factors of antiepileptic drug (AED) non-adherence. METHODS: We conducted a subgroup analysis based on results that emerged from a single center, cross-sectional study. Patients who were 18 years or older were included. The 4-item Morisky Medication Adherence Scale was used to measure adherence to AED (s). Multivariable logistic regression analysis was used to predict factors associated with AED non-adherence. RESULTS: A total of 268 patients fulfilled inclusion criteria and were included in this subgroup analysis. Among the participants, 81 (30%) were non-adherent to medication. Three factors associated with non-adherence were AED polytherapy [OR: 4.5 (2.1-9.5) P = 0.001], drug related adverse events [OR: 3.9 (2.1-7.3) P = 0.001], and treatment duration exceeding 3 years [OR: 2.6 (1.3-5.0) P = 0.003]. CONCLUSION: About one-third patients were not compliant with their medication. If the treatment of patients is restricted to monotherapy as far as possible and patients are educated about duration of treatment and possible adverse effects of AEDs, non-adherence may be reduced. Wolters Kluwer - Medknow 2021 2021-06-17 /pmc/articles/PMC8513971/ /pubmed/34728941 http://dx.doi.org/10.4103/aian.AIAN_925_20 Text en Copyright: © 2006 - 2021 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kumar, Shrawan Singh, Mamta Bhushan Kumar, Amit Padma Srivastava, M V Goyal, Vinay Medication Adherence in Indian Epilepsy Patients |
title | Medication Adherence in Indian Epilepsy Patients |
title_full | Medication Adherence in Indian Epilepsy Patients |
title_fullStr | Medication Adherence in Indian Epilepsy Patients |
title_full_unstemmed | Medication Adherence in Indian Epilepsy Patients |
title_short | Medication Adherence in Indian Epilepsy Patients |
title_sort | medication adherence in indian epilepsy patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513971/ https://www.ncbi.nlm.nih.gov/pubmed/34728941 http://dx.doi.org/10.4103/aian.AIAN_925_20 |
work_keys_str_mv | AT kumarshrawan medicationadherenceinindianepilepsypatients AT singhmamtabhushan medicationadherenceinindianepilepsypatients AT kumaramit medicationadherenceinindianepilepsypatients AT padmasrivastavamv medicationadherenceinindianepilepsypatients AT goyalvinay medicationadherenceinindianepilepsypatients |